Section 8: Thermal ablation - 24/11/22

Doi : 10.1016/j.ando.2022.10.011

Adrien Ben Hamou ^a,^b, Edouard Ghanassia ^b,^c, Arnaud Muller ^d,^e, Miriam Ladsous ^f, Nunzia Cinzia Paladino ^g, Laurent Brunaud ^h, Laurence Leenhardt ^a,^i,^⁎ , Gilles Russ ^a,^i,^j
^a Thyroid and Endocrine Tumors Department, Institute of Endocrinology, Pitié-Salpêtrière Hospital AP-HP, Sorbonne University, 75013 Paris, France
^b American Hospital of Paris, Thyroid Unit, 92200 Neuilly-sur-Seine, France
^c Polyclinique Sainte-Thérèse, 34200 Sète, France
^d Department of Imaging, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 69495 Pierre Bénite, France
^e Imagerie Médicale Val d’Ouest - Charcot, 53 Rue du Commandant Charcot, 69110 Sainte-Foy-Lès-Lyon, France
^f CHU Lille, Service d’Endocrinologie, Diabétologie, Métabolisme et Nutrition, Hôpital Claude Huriez, 59000 Lille, France
^g Aix Marseille Univ, APHM, Department of General Endocrine and Metabolic Surgery, Conception University Hospital, 13005 Marseille, France
^h Department of Gastrointestinal, Metabolic and Cancer Surgery (CVMC), CHRU Nancy, 54511 Vandœuvre-Lès-Nancy, France
ⁱ Institute of Cancer IUC Sorbonne University GRC N°16, 75013 Paris, France
^j Centre de Pathologie et d’Imagerie, 14, Avenue René-Coty, 75014 Paris, France

^⁎Corresponding author. Thyroid and Endocrine Tumors Department, Institute of Endocrinology, Pitié-Salpêtrière Hospital AP-HP, Sorbonne University, 75013 Paris, France.Thyroid and Endocrine Tumors Department, Institute of Endocrinology, Pitié-Salpêtrière Hospital AP-HP, Sorbonne UniversityParis75013France

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Thursday 24 November 2022
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). This section deals with thermal ablation, which may constitute an alternative to thyroid surgery in selected patients.

Le texte complet de cet article est disponible en PDF.

Keywords : Thyroid nodule, Thermal ablation, Radiofrequency, Laser, Ethanol ablation, Consensus